FundedIQ
Biotechnology

S2 Genomics: Funding, Investors & Team (Oct 2026)

S2 Genomics is a company that is working on creating solutions for spatial sequencing technology, specifically for the processing of solid tissues for single-cell applications. Their technology allows for the automated processing of raw tissues into individual cells or nuclei, which can then be used for various genomic and cell biology studies. The company's main goal is to develop products that can efficiently prepare raw tissues for genomic analyses. S2 Genomics was established in 2016 and is based in Livermore, CA.

s2genomics.com LinkedIn Livermore, United States 11-50 employees
Total raised
$18.2M
Rounds
2
Latest
Series A
Jan 2024

S2 Genomics has raised $18.2M across 2 funding rounds on record, the most recent a Series A of $16.0M announced in Jan 2024.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

S2 Genomics Company Profile and Key Stats

Total funding raised
$18.2M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Series A
$16.0M in Jan 2024
Employees
11-50
reported band
Headquarters
Livermore, United States

Latest funding round on record: Jan 2024.

S2 Genomics Funding Rounds

Date
Round
Amount
Series A
$16.0M
Undisclosed round
$2.2M

S2 Genomics raised $2.2M in an undisclosed round announced in May 2021.

2.7 years later, a Series A of $16.0M was announced in Jan 2024.

S2 Genomics Founders and Leadership Team

Name
Role
Contact
Peter Wagner
Founder
Locked
Stevan Jovanovich
CEO
—

Contact details for the S2 Genomics team: 1 of 2 have an email address on file.

Start 14-day free trial →

S2 Genomics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M
8,558
$15M

S2 Genomics' latest round of $16.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like S2 Genomics in Biotechnology and Livermore

Companies Similar to S2 Genomics

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

S2 Genomics Funding FAQs

What does S2 Genomics do?

S2 Genomics is a company that is working on creating solutions for spatial sequencing technology, specifically for the processing of solid tissues for single-cell applications. Their technology allows for the automated processing of raw tissues into individual cells or nuclei, which can then be used for various genomic and cell biology studies. The company's main goal is to develop products that can efficiently prepare raw tissues for genomic analyses. S2 Genomics was established in 2016 and is based in Livermore, CA.

How much funding has S2 Genomics raised?

S2 Genomics has raised $18.2M across 2 rounds on record. The most recent is a Series A of $16.0M announced in Jan 2024.

When did S2 Genomics last raise funding?

S2 Genomics' most recent funding round on record is a Series A of $16.0M, announced in Jan 2024.

Who founded S2 Genomics?

FundedIQ lists Peter Wagner (Founder) at S2 Genomics.

Who is the CEO of S2 Genomics?

Stevan Jovanovich is listed as CEO at S2 Genomics.

Where is S2 Genomics headquartered?

S2 Genomics is based in Livermore, California, United States.

How many employees does S2 Genomics have?

S2 Genomics is in the 11-50 employee band.

How does S2 Genomics' funding compare to other Biotechnology startups?

S2 Genomics' latest round of $16.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's S2 Genomics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for S2 Genomics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.